Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Eden

Showing results (191-200 of 286) with videos related to

Pageof 29
Sort By:
Community Mental Health Journal|June 12, 2020
Developing a Sound Body: Open Trial Results of a Group Healthy Lifestyle Intervention for Young Adults with PsychosisJulia Browne, Corinne Cather, Vanya Zvonar, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 9, 2022
Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imagingJodi M Gilman, William A Schmitt, Kevin Potter, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|March 4, 2010
Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidoneDavid C Henderson, Bikash Sharma, Xiaoduo Fan, et al.
Schizophrenia Research|September 19, 2008
Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory studyDonald C Goff, Corinne Cather, Jennifer D Gottlieb, et al.
JAMA Network Open|January 30, 2026
Detection of Δ9-Tetrahydrocannabinol Impairment Using Resting-State Functional Near-Infrared Spectroscopy: A Randomized Clinical TrialMoshe Berchansky, A Eden Evins, Bryn Evohr, et al.
Biological Psychiatry|April 2, 2002
Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapineDonald C Goff, John Hennen, In Kyoon Lyoo, et al.
Schizophrenia Research|December 14, 2016
Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorderA Eden Evins, Susanne S Hoeppner, David A Schoenfeld, et al.
Experimental and Clinical Psychopharmacology|December 9, 2009
Brain fMRI reactivity to smoking-related images before and during extended smoking abstinenceAmy C Janes, Blaise deB Frederick, Sarah Richardt, et al.
Neuroimage|May 11, 2019
Delta-9-tetrahydrocannabinol intoxication is associated with increased prefrontal activation as assessed with functional near-infrared spectroscopy: A report of a potential biomarker of intoxicationJodi M Gilman, Meryem A Yücel, Gladys N Pachas, et al.
Frontiers in Psychiatry|April 3, 2023
A randomized controlled trial of varenicline and brief behavioral counseling delivered by lay counselors for adolescent vaping cessation: Study protocolRandi M Schuster, Corinne Cather, Gladys N Pachas, et al.
Pageof 29

Showing results (191-200 of 286) with videos related to

Sort By:
Pageof 29
Community Mental Health Journal|June 12, 2020
Developing a Sound Body: Open Trial Results of a Group Healthy Lifestyle Intervention for Young Adults with PsychosisJulia Browne, Corinne Cather, Vanya Zvonar, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 9, 2022
Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imagingJodi M Gilman, William A Schmitt, Kevin Potter, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|March 4, 2010
Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidoneDavid C Henderson, Bikash Sharma, Xiaoduo Fan, et al.
Schizophrenia Research|September 19, 2008
Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory studyDonald C Goff, Corinne Cather, Jennifer D Gottlieb, et al.
JAMA Network Open|January 30, 2026
Detection of Δ9-Tetrahydrocannabinol Impairment Using Resting-State Functional Near-Infrared Spectroscopy: A Randomized Clinical TrialMoshe Berchansky, A Eden Evins, Bryn Evohr, et al.
Biological Psychiatry|April 2, 2002
Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapineDonald C Goff, John Hennen, In Kyoon Lyoo, et al.
Schizophrenia Research|December 14, 2016
Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorderA Eden Evins, Susanne S Hoeppner, David A Schoenfeld, et al.
Experimental and Clinical Psychopharmacology|December 9, 2009
Brain fMRI reactivity to smoking-related images before and during extended smoking abstinenceAmy C Janes, Blaise deB Frederick, Sarah Richardt, et al.
Neuroimage|May 11, 2019
Delta-9-tetrahydrocannabinol intoxication is associated with increased prefrontal activation as assessed with functional near-infrared spectroscopy: A report of a potential biomarker of intoxicationJodi M Gilman, Meryem A Yücel, Gladys N Pachas, et al.
Frontiers in Psychiatry|April 3, 2023
A randomized controlled trial of varenicline and brief behavioral counseling delivered by lay counselors for adolescent vaping cessation: Study protocolRandi M Schuster, Corinne Cather, Gladys N Pachas, et al.
Pageof 29